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The incidence of intracc ronary thrombus and the effects of
thrombolytic therapy were studied in 41 patients with
unstable angina . AH patients underwent coronary angiog-
raphy 2 to 69 h (mean 19) after their last attack of chest
pain
. Immediately after angiography, 21 patients received
iatracoronary streptokinase (250,000 III in 45 min) and
were retrospectively analyzed . Twenty patients received
intravenous
recombinant tissue-type plasminogen activator
(art-PA) (100 mg to 3 h) and were involved in a prospective
study .
Eleven of the 21 patients from the streptokinase group
and 11 of the 20 patients from the rt-PA group showed a
decrease in the severity of the coronary stenosis on repeat
anglography 1 day later. A decrease in coronary obstruc-
tion was primarily observed in 10 of 13 patient with a
complete stemosis and in 6 of 9 patients with a subtotal
stenosts and markedly diminished coronary flow . Improve-
ment in coronary anatomy was not determined by the
In 65 to 90% of patients with acute myocardial infarction, a
thrombotic obstruction is observed in the infarct-related
coronary artery (I). Depending on the type of thrombolvtic
agent and the mode of administration, thrombolytic therapy
results in recanalization of the infarct-related coronary ar-
tery in 40 to 88% of patients . This leads to limitation of
infarct size, preservation of global and regional left ventri-
cular function and improved I year survival (2-15).
In patients with unstable angina pectoris, angiographi-
cally detected intracoronary thrombosis has been described
in a number of studies (16-22), with considerable variation in
the reported incidence. In a recent study (23), angioscopy of
the coronary arteries during coronary artery bypass surgery
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clinical characteristics of the patients . Twenty-eight of the
41 patients had aagiographie evidence of intraroronary,
tIt combos formation before and 16 had such evidence after
thrombolytic treatment
. Nine patients developed a small
increase in serum cardiac enzymes before or during treat-
ment . Iscbemic symptoms and the incidence of magical "
angioplastic intervention were not different in patients with
or without a reduction in coronary artery stenosis after
fibrinotytic therapy.
These observations suggest a high incidence of coronary,
thrombosis in patients with unstable angina . The data do
not permit assessment of the clinical therapeutic efficacy of
thrombolytic therapy. Better risk stratification and place-
bo-controlled
prospective studies are required to obtain
information an the risk/benefit ratio of such therapy in
unstable angina
.
(J Am Coll Cordial 1980 :12 :301-9)
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revealed a high prevalence of intracoronary thrombus in
patients with unstable angina refractory to medical treat-
ment
. This was not observed in patients with stable angina .
In patients with unstable angina, administration of throm-
bolytic agents might be
effective in dissolving the thrombus
and improving coronas y flow . Such intervention might result
in a diminished risk of myocardial infarction and death
. The
purpose of the present study was to investigate the coronary
artery anatomy in patients with unstable angina and to
evaluate the effect of thrombolytic agents on coronary
anatomy an, outcome during hospital stay and during a 3
month follow-up period.
Methods
Patient selection
. From March 1986 through February
1987, patients with unstable angina entered the study . Selec-
tive coronary arteriography and left ventriculography were
required within 24 h after admission to the hospital
. The last
episode of chest pain had to o_cur whithin 48 h before
0735-1097188153.50
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hospital admission . If the patient had chest pain on or after
admission, ischemic electrocardiographic (ECU) changes
were criteria for entry into the study . If the patient had
symptoms only before hospitalization and was admitted with
the clinical diagnosis of unstable angina, he or she could be
included into the study in the absence of ECG ST segment
abnormalities .
In the first part of the study, 21 patients received intra-
coronary streptokinase in the artery thought to be responsi-
ble for the unstable angina and the abnormal (ECG). A clot
was thought to be present in this artery. These patients were
retrospectively analyzed .
In the secondpart of the study, 26 patients with unstable
angina were accepted for a prospective trial . In two patients,
we were unable to perform cardiac catheterization. In four
patients (three with a normal and one with an abnormal ECG
after chest pain but before admission), no coronary artery
disease was found at cardiac catheterization and, therefore,
no fibrinolytic therapy was given . The remaining 20 patients
received intraverous thrombolytic therapy and were ana-
lyzed .
According to studies (3-6,11,12) in patients with acute
myocardial infarction, the efficacy of the two thrombolytic
agents (in terms of patency rate) is more or less the same if
streptokinase is given in the intracoronary mode and ri-PA is
administered intravenously . This was one of our reasons for
combining the data for both treatment groups .
The study was approved by the hospital's institutional
review board
.
Diagnosis of unstable angina. This diagnosis was made
independently by two experienced cardiologists, and defined
as angina of recent onset, sudden worsening of preexisting
stable angina or postinfarction angina developing after an
asymptomatic period of ?3 months and classified as New
York Heart Association functional class III or IV
. The
symptoms of unstable angina had to start within the last 6
weeks before admission to hospital and could include re-
peated episodes of chest pain of long duration
(>20 min) at
rest or after minimal exercise .
Other inclusion and exclusion criteria . Inclusion criteria
were age up to and including 70 years and disappearance or
marked relief of pain after sublingual or intravenous nitro-
glycerin. Excluded were patients with severe valvular heart
disease, (class III and IV) heart failure, cardiomyopathy,
previous heart surgery or angioplasty, pacemaker, anemia
(hemoglobin <5
.5 mmol/liter), heart rate > 100 or <50 beats!
min at rest in the absence of chest pain, aTrhythmia-induced
angina pectoris, contraindications for thrombolytic therapy
or absence of consent
. In addition to these clinical criteria,
ECG and laboratory data were used to support the diagnosis
of unstable angina.
Electrocardlogrophic findings . All patients had a 12 lead
ECG recorded on admission
. When the patient had chest
pain after hospital admission, tracings were also recorded
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during and after such an attack
. These recordings were
classified as showing only ST-T segment abnormalities, both
QRS complex and ST segment abnormalities or no abnor-
malities at all. ST-T segment abnormalities were defined as
ST segment changes during pain or after chest pain.
If the patient had angina on or after hospital admission,
ECG changes were required. The ST segment ci;anges
during pain consisted of distinct elevation or depression of
the ST segment (in, respectively, I I and 7 patients) . These
changes had to disappear or markedly diminish spontane-
ously after either sublingual or intravenous nitroglycerin . If
the patient had chest pain before hospital admission, the
ischemic ST-T segment abnormalities after chest pain con-
sisted of an abnormal upsloping or downsloping ST segment
in combination with an inverted T wave, or horizontal ST
segment depression (in, respectively, 15 and 6 patients).
Patients with abnormal Q waves were only accepted if
there were previous electrocardiographic recordings docu-
menting Q waves that represented prior myocardial infarc-
tion . Two patients who had chest pain suggestive of unstable
angina before admission but no ECG abnormalities on ad-
mission were also entered into the study .
Cardiac enzyme measurements . Serial serum enzyme val-
ues for creative kinase, serum glutamic oxaloacetic trans-
aminase and serum lactic dehydrogenase were determined in
all patients every 6 h for 3 consecutive days. These deter-
minations were obligatory in patients with chest pain of long
duration and had to be less than twice the upper limit of the
normal value 6 h after the last attack of prolonged chest pain .
Coronary arteriography and left vevtrkulegraphy . Coro-
nary angiography was first performed within a median period
of 9 h (range 2 to 69) after the last attack of chest pain. In 40
patients it was repeated I day later (mean 25 h) ; in one
patient who developed bleeding, the restudy was carried out
after 8 days.
The angina-producing artery was identified with the fol-
lowing criteria . In 17 patients with significant single vessel
coronary disease, this vessel was considered to be the
ischemia-related artery . In 22 patients with multivessel dis-
ease, the angina-producing artery was designated by the
severity of the stenosis, aided by the location of ischemic
ST-T segment changes during pain at rest (II patients) or
after pain (I l patients) . In eight of the former and in six of
the latter patients with multivessel disease, the ischemia-
producing lesion corresponded with a hypokinetic left ven-
tricular wall segment, illustrating the hemodynamic signifi-
cance of the coronary obstruction
.
One patient had "distant ischemia ." After thrombolytic
therapy, perfusion of the less severely diseased circumflex
coronary artery improved and led to better retrograde filling
of the occluded left anterior descending coronary artery . In
this patient, the left circumflex coronary artery, which
supplied the collateral vessels, was selected as the artery of
interest . In one patient with a normal ECG and two vessel
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disease, we could not prospectively identify the ischee,ia-
related artery . After intracoronary infusion of streptokinase .
one vessel showed a significant decrease in lesion severity
and was designated retrospectively the angina-producing
artery.
The stenosis in the ischemio-related coronary artery was
independently judged by three experienced angiographers
and subjectively graded according n) a modified method of
the European Cooperative Study Group into one of the
following categories : 0 = normal vessel: I = mild stenosis of
<50% of the vessel diameter ; 2a = moderate stenosis 050%
but <70% ; 2b = moderate stenosis >_70% but <90% ; 3 =
severe stenosis o90% and complete filling of the distal vessel
within three cardiac cycles not through collateral vessels ; 4
= subtotal occlusion without distal filling within three car-
diac cycles
; and 5 = total occlusion with or without collat-
eral filling (11) .
Coronary artery dimensions were also assessed quantita-
lively by means of a previously validated and described (24)
computer-based cardiovascular angiography analysis system
(CAAS) using high resolution digital subtraction images .
This semiautomatic system has a highly reliable and repro-
ducible edge detection algorithm . which can assess the
stenosis diameter (SEM for short-term repeat measurements
of the obstructive diameter being 0.34 mm) . Area stenosis
was calculated with videodensitometry . The profile across
the vessel image was measured at the point of greatest
narrowing and compared with that of the normal segment,
thereby enabling calculation of the area stenosis as a func-
tion of luminal area . This is independent of its cross-
sectional shape.
Qualitative techniques utilizing vessel magnification f x2)
were performed to identify intracortntary thrombosis (25 .20).
Thrombosis was considered to be likely i€a total occlusion of
the coronary artery had irregular convex margins at if a
nontotal occlusion showed irregular shaggy margins or an
eccentric stenosis in the form of a convex intraluminal
obstruction.
Collateral vessels were considered present
if there was
visualization of the artery differently from anterograde flow
after injection of the contrast medium into another artery or
into a proximal segment of the same artery that "joined" the
obstructed distal segment .
In 38 of the df patients, abnormalities in left
rentricvlar
wall motion were judged at the first cardiac ratheterization
serving to identify the angina-producing artery in the 30'
right anterior oblique and the 60' left anterior obii : Ws .
and calculated according to a modified method of tn6els et
al. (27). From these projections, the left ventricular silhou-
ette was divided into several segments (anterobasal
. antero-
septal, anterolateral, apical, posterobasal, diaphragmatic
and posterolatera0. In the remaining three patients, the left
ventriculogram was not performed or of poor quality .
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Thrombolytic agent and heparin administration . After
baseline angiography. the thrombolytic agent was adminis-
tered . In the first part of the study, intracoronary streptoki-
nase was infused at a rate of 6 .000 Ulmin . The total dose
given was 250.600 IU . All these patients also received 100
mg of prcdnisolone intravenously . In the second part of the
study, intravenous single-chain recombinant tissue-type pla-
sminogen activator (rt-PA) was administered in the coronary
care unit immediately after completion of baseline angiogra-
phy . Ten mg was given as an intravenous bolus injection,
followed by an intravenous infusion of 50 mg in the first hour
and 20 mg in both the second and the third hour .
At the start of the first catheterization, all patients
received
heparin
by an intraarterial bolus injection of] mgt
kg body
weight
. In the patients treated with streptokinase,
heparin was only given after thrombolytic therapy if the
plasma fibrinogen concentration (measured every 3 to 4 h)
had returned to values of 80 .5 gititer
. In the study group
treated with rt-PA, heparin was continued intravenously
after thrombolytic therapy until the repeat angiography . The
dosage of heparin was titrated depending on laboratory
values measured every 3 to 4 hours . The aim of the titration
was a prothrombine time of two to three times the upper
limit of normal.
Treatment regimen . Medical management consisted of
therapeutic doses of a beta-adrenergic blocking agent (Lo-
preset), a nitrate (Mono-cedecard) and a calcium channel
blacker (Tildiem) given when indicated . Antiplatelet drugs
(aspirin, dipyridamole) were added after the second cardiac
catheterization.
Follow-up. All patients who received thrombolytic ther-
apy were followed-up for >_3 months after admission
. The
incidence of persistent unstable angina pectoris, myocardial
infarction, death, coronary bypass graft surgery as well as
coronary angioplasty was recorded .
Results
Patient characteristics. For the 41 patients receiving
thrombolytic therapy, data on age, gender, previous history
of angina pectoris, previous myocardial infarction, severity
and duration of angina) complaints and enzyme changes
before catheterization are given in Table I . Fifteen patients
had a prior history of stable angina, half had rest angina of
new onset and 21 patients experienced episodes of chest pain
of long duration
.
Ang'wgraphic findings. Table 2 gives information on the
incidence of single, double and triple vessel disease and the
location and severity of the coronary lesion thought to he
responsible for the unstable angina and the ECG abnormal-
ities . Twelve of the 13 patients with a completely occluded
vessel and 5 of the 9 patients with a severely narrowed vessel
and sluggish anterograde flow had collateral circulation, At
the second cardiac calheterization,these collateral ver •els
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Table 1. Clinical Characteristics of the 41 Patients on Entry to
the Study
n-PA = recombinant tissue-type plasminogen activator ; SK = Rreptoki-
were visible in only II patients
. Angiographic findings
suggestive of intracoronary thrombus formation were pres-
ent in 28 of the 41 ischemia-related vessels before throm-
bolytic therapy. At the second angiographic study, these
findings were still present in
16
patients. The baseline
contrast left ventriculogram revealed localized regions of
abnormal wall motion during systole in 28 of 38 patients .
Complications . We observed a low complication rate in
our patients with unstable angina. Although many patients
had oozing at puncture sites and a decrease in hemoglobin
Table 2. Results of Baseline Coronary Angiographlc and Left
Ventriculographic Characteristics in the 41 Patients
(38 patients)
LAD = :en anterior descending coronary artery ; LCx= left circumflex
coronary artery ; RCA = right coronary artery; other abbreviations as in
Table 1 .
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Figure 1 . Coronary artery diameter narrowing before and after
thrombotysis. Subjective analysis (according to a modified method
of European Cooperative Study Group [III) . CAT = category of
vessel ; I = first catheterization ; Il = second catheterization ; rt-PA
= recombinant tissue-type plasminogen activator ; SK = streptoki-
nase.
level (mean 0.3 mmol/liter), only one patient had bleeding at
that site accompanied by retroperitoneal leakage requiring
blood transfusion. Ventricular fibrillation occurred once in
this patient and was promptly and successfully treated by
external electrical countershock .
Effect of thrombolytlc therapy on coronary anglogaphle
findings. Figure I demonstrates the subjective analysis and
Table 3 the quantitative analysis of the coronary angio-
graphic findings before and after thrombolysis . Figure I
shows that the effect of thrombolytic therapy was most
marked in occluded or severely narrowed vessels . This was
confirmed by the quantitative analysis in which a marked
improvement was found in the vessels narrowed >90% and
no improvement was detected in vessels with
<90%D steno-
sis. Table 3 indicates a 16% reduction (p <0.05, paired t test)
of diameter stenosis in all patients and a 69o reduction (p <
0.01, paired r test) of area stenosis in 30 of the 41 patients
. In
11 patients with an extensively diseased ischemia-related
Table 3
. Coronary Artery Diameter Narrowing Before and After
Thrombolysis: Quantitative Analysis (by CAAS)
Streptokinase n-PA
CAAS= Cardiovascular Angiogmphy Analysis System ; I =first cardiac
catheterbation; It - second cardiac emhetesization.
SK n-PA Total
No. of patients 21 20 41
No. of diseased vessels
Dan
It 6 17
Two 8 7 Is
Three
2 7 9
Ischemia
.related vessel
RCA 4
5
9
LAD 12 8 20
LCx 5 7 12
Total obstruction
9 4 13
Thrombus in nunoccluded vessnls(28 patient,)
7 8 IS
Collateral vessels
12 4 20
Ischenia-related abnormal wall motion
14 14 28
SK n-PA
Total
No. of patients 21 20 41
Age lyr) (mcan t SD) 58 t 9 58 t 6
58 t 7
No. of man
17
16
33
Previous angina (>6 weeks) 8 7 IS
Prvicus myocardial infarction 3 6
9
Duration of unstable angina an entry
(days)
Meant SD 706 8±11 809
Median 4 1
4
Severity of angina on entry
Class III 5 6 11
Class 1V, province angina
6 4 IO
Class IV, angina of new onset 10 10 20
Last attack of angina of long
duration (>20 min)
Creation kinase
9
Il
21
Normal 19 17 36
Abnonnal (to to lx upper limit of 2 3 5
nonnall
1
11
11
No. of patients analysed 21 20
Diameter stenosis (%)
(mean ± SD)
77 t 21 67 t 20 65 ± 22 51 t 19
No . of patients analyzed 17 13
Area slenosis (%)
(mnon t SDI
92 ± 9 88 t 11 93 t 9 85 t 15
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Table 4. Coronary Artery Diameter Narrowing Before
Thrombolysis (assessed by subjective analysis): Clinical
Characteristics of 41 Patients at the Last Episode of Chest
Pain, Peak Creative Kinase Value and Collateral Vessels
at the First Cardiac Catheterization
vessel, it was not possible to derive a reliable measurement
of area stenosis
.
Coronary steelonis severity and clinical cbaracteristlcs . Ta-
ble 4 compares the coronary artery diameter narrowing
before thrombolysis (as assessed by subjective analysis) and
the clinical characteristics of the patients at the last attack of
chest pain. The 10 patients with the most severely narrowed
vessels (category 4 or 5) seemed to More a more frequent
history of previously stable angina cc mpared with the 5
patients with only moderate stenosis. N ) relation was found
between the severity of coronary steno ;is and the duration
and severity of angina.
In the 22 patients showing
a reduction in the uctae
coronary artery diameter narrowing )accord toe to subjective
analysis), we attempted to correlate this improvement with
the clinical characteristics at entry into the study and the
coronary angiographic findings before thrombolysis. Except
for a greater incidence of a complete or subtotal vessel
occlusion, no clinical characteristics or remaining angio-
graphic findings were different from those of the total study
group. Otherwise, improvement in coronary artery diameter
narrowing did not result in improvement in functional class
or a lower incidence of coronary bypass surgery or angio-
plasty .
We also attempted to correlate the improvement in func-
tional class after thrombolysis and during hospitalization
with clinical and angiographic variables in 26 patients .
Except for a somewhat shorter mean duration of unstable
angina (5 versus 8 days in the total study group), none of the
remaining clinical characteristics or angiographic findings
DE ZWAAN ET AL .
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Table 5 .
Reduction in Coronary Artery Diameter Narrowing
After Thrombolysis )assessed by subjective analysis) :
Improvement in Functional Class, Incidence or Coronary Bypass
Surgery or Coronary Angioplasty at Discharge From the Clinic
Coronary Artery Anatomy
No. of Patients Improved Not Improved
Angina class I . 11 26 14 12
CABG-PTCA 14 a 6
CABG = coronary artery bypass graft ; PTCA = percutaneous trmslum-
inat coronary angioplasty .
were different from those of the total study group . In
addition, improvement in functional class was not based on
a decrease in the severity of coronary artery stenosis (Table
5).
Follow-up. Myocardial infarction . Follow-up data con-
cerning the incidence of myocardial infarction, coronary
bypass graft surgery or coronary angioplasty and functional
class after treatment can be summarized as follows . Before
or during thrombolytic treatment, nine patients had a small
myocardial infarction . During hospitalization, an additional
four patients developed a small myocardial infarction on an
average of 6 days after entry in the study.
The mean duration of unstable angina pectoris in the
group with infarction before or during thrombolysis was
shorter than that in the total study group (4 versus 8 days)
. In
all these patients the total duration of the last attack of chest
pan was >45 min (mean 130), but there were no ECO signs
of a new developing myocardial infarct on entry into the
study . Five had relief but not complete disappearance of
pain within 40 min after beginning treatment in the clinic .
Six of the nine patients in the group with infarction before
or during thrombotysis and none of the four patients with
infarction "after" thrombolysis showed no or only sluggish
anteroerade flow in the ischemia-related vessel at the first
cardiac catheterization . According to the baseline angio-
gram. 8 of the 13 patients did not have collateral vessels to
protect the jeopardized myocardial tissue.
The highest mean creatine kiuase values in the 13 patients
with myocardial infarction were 2.2 and 3 times, respec-
tively, the upper limit of normal in the patients with infarc-
tion before or during versus after thrombolysis. Only one of
the nine patients with infarction before or during thromboly-
tic therapy and two of the four with infarction after this
treatment showed a small Q wave and some R wave loss on
the ECG at discharge. In eight patients, the QRS complex
did not change .
Persisting or recurring angina
. Eight of the 21 patients
treated with streptokinase and 7 of the 20 patients receiving
rt-PA continued to have anginal pain (clan! Ill and IV) in the
hospital . Fourteen patients were treated during their hospital
stay by coronary bypass graft surgery (10 patients) or
coronary angioplasty (4 patients) . After discharge, an addi-
Category of Vessel
4',5 3
No, of patients 22
Previously stable angina pectotis 16
Duration of unstable angina (days)
McaotSD
7cIt 8tIn
Median 4 3
Severity of last attack of angina
Class 111 6
Class IV 16
Time interval between last attack of
angina and first catheterieation
eht
Mean o SD 21 t
19
17
18
Median 13 10
Peak creadne kinase
I x to Zx upper limit of normal 3 1
>2x
upper limit of normal
Csrllatrr
aJ vessels pretest
3
17 3
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tional number of patients had recurrent angina, leading to
bypass surgery in three and angioplasty in two
.
At the end of the 3 month follow-up period, 31 patients
were in functional class I and 8 patients in class II
. No
patient died or developed myocardial infarction after dis-
charge from the clinic.
Discussion
The term "unstable angina" has been applied to a heter-
ogeneous group of patients with a variety of clinical presen-
tations that have in common a picture of presumed acute
myocardial ischemia and are characterized by an unpredict-
able clinical course. Increasingly severe obstructive coro-
nary stenosis, coronary spasm (28) and platelet aggregates,
alone or in combination, have been implicated as causes of
unstable angina pectoris.
Coronary artery distribution and severity of stenosis . Pa-
tients with unstable angina have a higher incidence of left
main coronary artery disease and perhaps of proximal left
anterior descending coronary artery disease than do patients
with stable angina pectoris (29). In our study, 20 of the 41
patients had a diseased left anterior descending coronary
artery; none had significant left main stem disease as the
"culprit" artery.
Coronary occlusion is frequently found in patients during
the evolution of Q wave myocardial infarction (1) and less
often in early non-Q wave myocardial infarction (30) . Among
our patients with unstable angina pectoris, 50% demon-
strated a complete or almost totally occluded ischemia-
related vessel, a finding in agreement with the study of
Plothick et al . (31) . In the streptokinase-treated group, this
finding was more prevalent than in the rt-PA-treated group.
A possible explanation is that in the
streptokinase study
group, the rest its were retrospectively analyzed and the
vessels had to be "suitable" for treatment with a fibrinolytic
agent. The data from another study (30) suggest that
the rate
of occlusion increases with the duration of the time interval
between the last attack of chest pain and baseline angiogra-
phy . In the streptokinase-treated study group, this interval
was twice that of the rt-PA-treated study group (mean 25
versus 13 h)
. This finding is another possible reason for the
difference in the incidence of a complete
(or near totally)
occluded angina-producing vessel in both treatment groups .
Role of thrombus
. The incidence and the significance of
thrombus formation in unstable angina are less well defined
.
Suggestive evidence for thrombus formation in preinfarction
angina includes studies
( 7 2-34) indicating that one-third of
patients with an impending myocardial infarction develop
transmural infarction over a short interval
. Also, pathologic
anatomic studies (35-37) on coronary thrombosis in trans-
mural infarction have demonstrated a laminar appearance of
the thrombus with layers of varying age
. These observations
are consistent with several angiographic observations (16-
MACC V .I. 12, No . 2
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22) of partially occluding thrombi seen in these patients.
Furthermore, observations (23) using coronary angioscopy
during coronary bypass surgery suggest that unstable angina
refractory to medical treatment can be caused by pathologic
processes in the intima . The therapeutic effect of antiplatelet
aggregation medication (38,39)andtheresults ofphysiochem-
ical studies (40-44) in patients with unstable angina support
the important role of intracoronary thrombosis
.
Using our previously described criteria, we could identify
angiographic evidence of intracoronary thrombus formation
in 28 (68%) of 4l ischemia-related vessels before infusion of
streptokinase or rt-PA. Sixteen patients continued to have
angiographic evidence of thrombosis at the second angio-
graphic study. If this observation of a "high" prevalence of
thrombus after thrombolytic therapy is correct, it might
explain the high incidence of patients who remained refrac-
tory to medical treatment . Irregular shaggy margins or
eccentric stenosis may be caused, however, not only by
thrombosis, but also by ulceration of the intimal plaque.
Collateral flow . Development of collateral vessels plays
an important role in myocardial oxygen supply of the jeop-
ardized myocardium and the prevention of a large myocar-
dial infarct. The presence of collateral flow correlates with
the extent and severity of coronary artery disease (31,45,
46) . In the earlier mentioned study of Pletnick et al. (31),
collateral vessels were present in 91 of I10 totally obstructed
major coronary arteries and in 15 of 69 vessels with near
total (90 to 99%) occlusion. Collateral vessels were visual-
ized in our study in 12 of 13 totally occluded coronary
arteries, in S of 9 severely narrowed arteries with a sluggish
anterogmde flow and in only 3 of 15 severely narrowed
vessels with anterograde distal filling within three cardiac
cycles . At the second coronary angiography, the incidence
of these collateral vessels was lower (namely, Il patients),
indicating an improved or reestablished anterograde coro-
nary flow and a less threatened myocardium .
Thrombolysis and adgiographic changes . After streptoki-
nase or rt-PA administration, 10 of 13 occluded coronary
vessels showed recanalization, 12 vessels had a decrease in
the severity of stenosis and I vessel had an increase in
diameter narrowing. Therefore, angiographic evidence of
thrombolysis was demonstrated after the second angio-
graphic study in 22 of the 41 infusions with a thrombolytic
agent or in 19 of 28 vessels with a suggestion of intracoro-
nary thrombosis during baseline angiography . The decrease
in the incidence of complete or near total occlusion after
thrombolytic therapy suggests that the observed changes
were a result of thrombolytic therapy and not of spontaneous
resolution.
Previous studies on thrombolysis in unstable angina. Pre-
-it-,us clinical studies using streptokinase in unstable angina
demonstrated a range from minor to major angiographic
changes in native and bypass vessels . Rentrop et al. (2)
studied five patients with prolonged angina at rest and [toted
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no change in "subtotal" lesions after the intracoronary
administration of 128,000 IU (± 36 .000) of streptokinase .
This is in contrast with our data, in which the effect of
thrombolytic therapy was most marked in occluded or
severely narrowed vessels . Vetrovec et al . (18) administered
100,000 to 350,000 IU of intracoronary streptokinase in 12
patients with repeated prolonged episodes of angina at rest
of less than 2 weeks duration . They reported angiographic
"success" after 10 of the 12 infusions, although the majority
of patients had minor changes . In nine patients with pro-
longed or frequent recurrent angina at rest, Mandelkom et
al . (19) administered 240,000 lU of intracomnary streptoki-
ease, which resulted in angiographic "success" in four
patients. The differences in outcome between these studies
are probably related to differences in patient selection,
timing of the intervention in relation to episodes of chest
pain and total dosage of the thrombolytic agent .
In the recent study by Ambrose et al. (47) of 37 catheter-
ized patients with either an acute episode of unstable angina
(29 patients) or a recent non-Q wave infarction (8 patients)
and in whom a less than 100°% occluded ischemia-producing
artery could be identified, no significant changes in any
quantitative or qualitative variable were found after throm-
bolytic therapy. This inclusion of recent non-Q wave infarc-
tion and the exclusion of totally occluded vessels (showing
the most marked beneficial effect in our study) undoubtedly
explains the difference in total outcome between their study
and ours . Gold et al . (48) studied 23 patients with unstable
angina at rest and transient ST segment deviations of at least
1 mm ; 38 h (± 19) after infusion and a monitoring period of
2 to 28 h, they demonstrated a subocclusive thrombus in 0 of
11 patients receiving placebo, but in none of 12 patients
treated with rt-PA.
Subjective versus quantitative measurement of coronary
stenosis . In our study of unstable angina, improvement in
the severity of coronary artery stenosis was demonstrated
by both subjective and quantitative analysis . We do not have
an explanation why the effect was most marked in the
severely stenotic vessels and (similar to the study of Am-
brose et al . 147]) not in vessels having <90% diameter
narrowing. In this subgroup of patients, spasm can play a
(more important) role (28).
The explanation for the difference in results of the sub-
jective and quantitative measurements of coronary artery
narrowing has been provided by Me Mahon et al
. (49)
. The
subjectively graded minimal reduction in luminal diameter is
comparable with the quantitatively assessed area stenosis (in
patients with new onset of refractory rest angina and ische-
mia ST-T changes). We calculated only the diameter stenosis
and the area stenosis for quantitative measurements because
we wanted to quantify the subjectively graded minimal
Inminal diameter reduction, the variables we used for corre-
lation assessments. Also, the percent stenosis determined by
videodensitometric analysis correlated well with the percent
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reduction in cross-sectional area as measured postmortem
by histologic planimetry (r = 0.97) (50) .
Incidence of myocardial infarction. Thirteen of the 41
patients snowed an i--
.
.= (mean2.4-fold) in serum crea-
tine kinase during their hospitalization . This incidence is in
accord with previously reported data (32-34) that in one-
third of patients with an impending myocardial infarction
transmural infarction occurs over a short interval . The type
of infarction in our study was different, however ; only three
patients showed the development of small ECC Q waves . In
the absence of a placebo-controlled study, it is as yet
unknown if myocardial damage is less extensive after thrum-
bolytic therapy.
Clinical events. The effect of thrombolytic therapy on
anginal symptoms in this study group is unclear. Twenty-six
of 41 patients had a decline in symptoms during their 10 days
in hospital. The improvement in functional class did not
correlate with the reduction in the severity of coronary
artery stenosis. Many patients had only temporary clinical
benefit and experienced recurrent angnal pain, leading to
coronary angioplasty in 6 patients and bypass surgery in 13
during the 3 month follow-up period . These events were also
not related to the effect ofthrombolytic therapy on coronary
artery diameter narrowing or on the postthrombolytic anti-
thrombotic regimen which, although not uniform, was nev-
ertheless adequate . Because changes in pressure vary as the
fourth power of diameter stenosis (51), minimal (nondetect-
able) changes in coronary diameter may theoretically cause
a decrease or a further increase in episodes of ischemia in
unstable angina. In the study of Gold et al . (48), unstable
angina persisted after completion of the infusion in 6 of I I
patients receiving placebo (follow-up 7 ± 5 days) and in only
I of 12 patients receiving rt-PA (follow-up 8 ± 4 days) .
Definite conclusions regarding the clinical response to
thrombolysis in patients with unstable angina are not possi-
ble because of the small number of patients, the unknown
natural course of the coronary artery anatomy (spontaneous
resolution by means of endogenous thrombolysis) and the
relatively short follow-up periods . Furthermore, several of
these patients received a variety of additional phannacologc
agents, including heparin and aspirin (38,39,52), which may
have influenced the efficacy of fhrombolytic therapy .
Prognosis. A prognostic classification of patients with
unstable angina is currently not available but is urgently
needed because information about prognosis is essential to
determine the aggressiveness of diagnostic and therapeutic
interventions . Pain characteristics, response to conventional
medical therapy, objective evidence of the extent of the
ischemic area, previous myocardial infarction, coronary
anatomy and left ventricular function are all factors likely to
influence this prognostic classification
. Furthermore, the
risk and benefit of an aggressive approach with thrombolytic
therapy have to be determined .
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Conclusions. The syndrome of unstable angina appears to
be frequently associated with intaccnronary thrombosis, as
evidenced by angiographic changes seen before and after
thrombolytic therapy. The data from this study do not allow
us to make a complete assessment of the clinical efficacy of
such therapy . Placebo-controlled randomized studies are
required to determine the true value of thrombolytic therapy
in the management of unstable angina pectoris, to assess the
risklbenefit ratio of this type of therapy and to identify
subgroups of patients who would receive the greatest ben-
efit .
References
1 . De Wood MA, Spores J, No eke R . et al. Prevalence of total coronary
occlusion during The early hours of transmural myocardial infarction . N
En gi J Med 1980903:897-902.
2
. Rent" P
. Blankc H . Karsch KR. Kaiser H, Kostering IL Leilz K .
Selective Intmcoronary Iheombolysis in acute myocardial infarction and
unstable angina pectoris. Circulation 1981 :633x7-17.
3 . Anderson 3L. Marshall HW, Bray BE . et al . A randomized trial of
inlncoronary streprekinase in the treatment of acute myocardial infarc-
ies . N EngI I Med 1483;308:13125.
4 . Kennedy JW, Ritchie IL, Davis KB, Fritz 1K . Western Washington
Randomized Trial of Intmcoronary Streptokinase in Acute Myocardial
Infarction . N Engl I Med 1983:309 :1477-82 .
5 . Remrap KP
. Fail F. Blanke H .at al. Effects of intracorunary, sueptoki-
and intraceronary nitroglycerin infusion en coronary angiagnphic
patterns and mortality in patients with acute myocardial infarction . N
Erg] I Med 1984;311:145753 .
6. Simoons ML, Senuys PW, van den Brand M, et al . Improved survival
after early thrombolysis in acute myocardial infarction : a randomized trial
conducted by the I.C.I.N
. Lancet 19852
:57852 .
7 . Gmppa Italian per to Studio dell, Sueptahinesi nell'infano Miocasdico
(G15S0. Effectiveness of intravenous thrombolytic treatment in acute
myocardial infarction. lancet 1986:1:397401 .
8
. The LS
.A.M. Study Group
. A prospective trial of intravenous sueptoki-
o acute myocardial infarction (I
.S .A
.M,) . N Engl I Med 1986;314:
1465-71
.
9. ISIS Steering Committee . Intravenous streptokinase
given within 04
boors of onset of myocardial infaction reduced mortality in ISIS-2 .
/ .once/ 1987 ;1 :502 .
10. Vermeer F . Simmons ML, de Zwea P, al al . Cost benefit analysis of
early thrombolytic therapy with intncoranary sucptnkinase . Br Hear 1
(in press).
11 . TIMI Study Group, the Thrombolysis in Myocardial Infarction (TIM11
Trial
: phase 1 findings . N Engl I Med 1985310:932-5 .
12. Verslraele
hL Bury M, Collen D, et al . Randomised trial of intravenous
recombinant tissue type plasminagen activator versus intravenous steep
lnkinase in acute myocardial ia
:amdon. lancet 1985 :1 :842-7.
13 . Bece M . De Bono DP, Muir AL.
It
al. Clinical effects and kinetic
properties of intravenous APSAC-aeisoylated plasminoger-streptoki.
activator complex (BRL 26921) in acute myocardial infarction
. tell
Miol 1996 ;11 :53-51 .
14
. Coupon W. Maine- r, Wollschleger H, et d . Coronary thrombolysis
during acute myocardial infarction by intravenous BRL 26921, a new
nieoyiated plasminogen-streptokinase activator complex
. Am I Cardiol
198638:418-21 .
15. Van de Well F. Venhaecke J . do Gees, H, Vomlracte M
. Collen D
.
Coronary thmmholysis with recombinant single-chain
amkiruse-type
plasminogen activator in palicals with acute myocardial infarction. Cir-
culation 1986;74:1066-70 .
JACC Vol . 12, No. 2
Miner 1988 301-9
16. Vebovec GW, Cowley Ml. Ovenon H. Richardson OW. Intmcoronary
thrombus in
syndromes
of unstable myocardial ischemia. A. Head J
1991 :W2:1202-8.
17. Holmes DR Jr, Homier GO, Smith HC, Funer V. Coronary artery
thrombosis in patients with unstable angina . Br Head J 1981;45:411-6 .
18. Yet- GW, Leinbach RC, Gold HK, Cowley MI . Intmcoronary
thrombolysis in syndromes of unstable ischemia : angiogeophic and clini-
cal
results. Am Head 11982 :104 :946-52.
19. Mandelkom JR, Wolf NM . Singh S. et al . Intmcoronary Ihmmbus in
nontmnsmurel
myocardial
infarction and in unstable angina pectoris. Am
1 Cordial 1983:52:1-6 .
20. Ambrose JA, Winters SL, Stem A. et al . Anwographtc morphology and
the pathogenesis oinnstable angina pectoris . I Am Call Card!.] 1985;5:
609-I6.
21. Bresnahan DR, Davis JL, Holmes DR Jr . Smith HC . Angiognphic
occurrence and clinical correlates of intraluminai coronary artery throm-
bus : role of unstable angina . J Am Coll Cardiol 1985
;6:295-S.
22. Capone G . Wolf NM . Meyer B . Meister SO. Frequency of intracomnoey
filling defects by angiography in angina pectoris at rest . Am I Cordial
198536:403-6 .
23. Sherman CT. Lnvack F. Gmndfest W. It al . Corotimy angsoscopy m
patients with unstable angina pectoris . N Engt N Med 1986 .31531;T .
24 . Reiber 1HC, Senuys PW, Kooyman CJ, et al . Assessment of short-,
medium., and long-term variations in arterial dimensions from computee ,
.added quantitatronafcomnary cineaegmgram. Cirulation 1985 ;71 :280-
8 .
25 . Ambmse JA, Winters SL, Amm RR, et al . Angiographic evolution of
coronary eatery morphology in unstable angina . I Am Coll Cardiol 1986 ;7 :
472-8 .
26
. Wilson RF
. Holids MD, White CW
. Quantitative angiographic morphol-
ogy of coronary stenoses leading to myocardial intimation a unstable
angina. Circulation 106623:116A3 .
27 . Ingels NB Jr, Daughters Of, Sdnson EB. Alderman F.L . Evaluation of
methods for quantitating left ventricular segmental wall motion in man
using myocardial markers as a standard . Circulation 1980;61:966-72.
28
. Olive PB . Unstable rest angina with ST-segment depression : parhaphye.
iologic considerations. Ann Inlem Med 1984;100 :42440.
29. Plolnick GD, Greene HL, Carliner NH, Baker LC, Fisher ML . Clinical
indicators of left main coronary artery disease in unstable angina. Ann
Imem Med 1979 ;91,149-53.
30. Ds Wood MA. Stifmr WP. Simpsae C5, et al. Coronary aneriographic
Endings soon after non-Q.wave myocardial infarcion . N Engl J Med
1986:315:417-23.
31 . PldnickGD,Fisher ML,LemerB
.CarfinerNil. Peters RW,Beeline LC .
Collateral circulation in patients with unstable angina . Chen 1982;82 :719-
725.
32. Neill WA, Ritznaen LW, Selden R . The pathophysiologic basis of acute
coronary insufficiency: observations favoring the hypothesis of intermil-
tenl reversible coronary obstruction . Am Head J 1977;94 :439.44 .
33. Neill WA, Whonon TP Jr. Flood-Lundeen J, Cohen IS . Acute .-my
insufficiency-coronary occlusion sier intermittent isehemic attacks . N
Engl J Med 1980
:302
:1157-62.
34. HINT Research Group. Early treatment of unstable angina in the coro-
nary care unit: A randomised. double blind, plaeebo-controlled compar-
ison of recurrent ischaemia in patients treated with nifedipine or meto-
prolol or both. Be Hem 11986 ;56 :400.13.
35. Levin DC, Fallen Jr. SIPmficance of the angtagnpluc mrpaulogy
,
of
localized coronary stenoses
: hislopathologic canelations. Circulation
1982'.66 :316-20.
36. FaIkE.Unstableanginawithfmaloutwme:dynamicmronarythrombe.
sit leading to infarction and/or sudden death : autopsy evidence of
recureect maul thrombosis with peripheral emboliestion culminating in
total vascular occlusion . Circulation 1985 ;71 :699-7r9
JACC Vol. 12, No
. 2
August 1988 :301-9
37 . Feldman RL . Coronary thrombosis . coronary spasm and speculation an
the link between unstable angina and acute myocardial infarction . Am I
Cordial 1987 :59:1187)0.
38
. Lewis HD, Davis 1W, Archibald
DA
. e t al . Protective effect of aspirin
against ante myacadiaI infarction and death in men with unstable
angina
. N EngIJ Med 1983 :309:396-103 .
39. Cairns IA, Gent M, Singer 1 . et al . Aspirin, eolfirpyosoone. on both in
unstable angina : results of a Canadian multicenler trial . N feat l Med
1985:713:1369-75.
40. Full, 1D, Gallagher K, Rowe GG. Blood flow reductions in stenosed
canine coronary arteries : vcecapasoa or platelet aggregation? Circulation
1982,65 :248-55 .
41. Robertson RM . Robertson DM, Roberts Li, el al. Thromboxane A t in
vasotonie angina pectoris: evidence from direct measurements and inhi-
bition trials. N EngI N Will 19811304:998-1003 .
42 . IJirseh PD, Firth BG, Campbell WB. Dehmer G1. Willerson IT . Hillis
LU. Effects of provocation on transcaniac thromboxane in patients with
cammsy artery disease. Am J Cordial 1983 ;51 :727-33 .
43 . Buja LM, Willerson JT. Patnophysiology, of angina pectoris and acute
ischemic heart disease. Candiovaeu Rev Rep 1983;4 :1553-62.
44. Ftagenld DJ, Roy L, Cetefa F. FitzGerald GA . Platelet activation in
unstable coronary disease . N Engl J Med 1906;315 :983-9.
45 . Fuster V, Frye RL, Carnally DC . Danielsan MA . Elvrback I
.R
. Kurland
DE ZWAAN ET AL.
	
309
THROMOOLYTICTHERAPY IN UNSTABLE ANGINA
LT. Ancivoaphic patterns ealy in the onset of the coronary syndromes .
Or Hear J 1975 :37:1250-5 .
46. Garlic R . Fuster V, Ambrose IA. Anatomic-physiologic links between
acme coronary syndromes. Circulation 1986:74:69 .
47. Arab .... IA . Hjemdahl-Monsen C, Borrico S . el al . Quantitative and
qualitative effects of introcoronary stmplokitwso in unstable angina and
non-Q. . ." infarction . J Am Coll Candied 1987 ;RI156-65.
48. Gold HK. Johns JA. Leinbach R
C. e
t al . A acdomiecd, blinded
.
placeho-controlled trial of recombinant human tissue-type plasminogen
activator in patients with unstable angina pectoris
. Circulation 1987
:75
:
1197-9 .
49. Me Mahon MM . Brown SG. Cukingnan R. et al. Quantitative coronary
angiagaphy: measuremenl of the "critical" slenusis in patients with
unstable angina aad
single-
sel disease wiltout callateals . Circulation
1979:60 :113
.
50. Nichols AS, Gabnieli CFO, Fenoglio 11, Esser PD . Quantilmlion of
relative coronary arterial stenosis by cinevideodensimmetric analysis of
coronary aneriogeams. Circulation 1984:69 :512-22 .
51 . Gould KL . Dynamic coronary stenosis . Am J Cardiol 1900:45:206-92.
52 . Telford AM . Wilson C . Trial of heparin unman alenolol in prevention of
myocardial infarction in intermediate coronary syndrome . lancet 1981 ;1:
1225-8 .
